Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Sell
48
SVA Quote, Financials, Valuation and Earnings
Last price:
$6.47
Seasonality move
:
13.44%
Day range:
$6.47 - $6.47
52-week range:
$6.25 - $6.58
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.50x
P/B ratio:
0.05x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$464.9M
Revenue:
$448.3M
EPS (TTM):
-$1.31
Earnings Data
Next earnings date for SVA
Aug 15
2025
Most recent earnings per share
$0.96
Beat by $0.96
(Dec 31/2020)
Consensus Estimate
--
(Dec 31/2020)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SVA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2020 | Q4 | -- | -- | $0.96 | -- | -- |
| 12/07/2020 | Q3 | -- | -- | $0.10 | -- | -- |
| 08/28/2020 | Q2 | -- | -- | -$0.05 | -- | -- |
| 04/30/2020 | Q1 | -- | -- | -$0.07 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | $0.20 | -- | -- |
| 11/15/2019 | Q3 | -- | -- | $0.06 | -- | -- |
| 07/10/2019 | Q2 | -- | -- | $0.11 | -- | -- |
| 04/29/2019 | Q1 | -- | -- | $0.01 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$0.03 | -- | -- |
| 11/08/2018 | Q3 | -- | -- | $0.12 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | $0.10 | -- | -- |
| 05/11/2018 | Q1 | -- | -- | $0.14 | -- | -- |
| 12/31/2016 | Q4 | -- | -- | $0.09 | -- | -- |
| 11/28/2016 | Q3 | -- | -- | $0.06 | -- | -- |
| 08/23/2016 | Q2 | -- | -- | -$0.17 | -- | -- |
| 04/05/2016 | Q1 | -- | -- | $0.02 | -- | -- |
| 12/31/2015 | Q4 | -- | -- | -- | -- | -- |
| 11/12/2015 | Q3 | -- | -- | -$0.03 | -$0.02 | -$0.01 |
| 08/12/2015 | Q2 | -- | -- | $0.04 | -$0.01 | $0.05 |
| 04/20/2015 | Q1 | -- | -- | -$0.04 | $0.02 | -$0.06 |
| 12/31/2014 | Q4 | -- | -- | $0.02 | $0.03 | -$0.01 |
Sinovac Biotech Earnings Questions
-
How Much did Sinovac Biotech Generate in Revenue Last Quarter?
Sinovac Biotech reported -- worth of top line sales in its most recent quarter.
-
Did Sinovac Biotech Beat Earnings Last Quarter?
Sinovac Biotech announced earnings per share of $0.96 which represents a beat of analyst forecast a -- per share.
-
Is Sinovac Biotech Profitable?
Sinovac Biotech reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Sinovac Biotech EPS Next Year?
Sinovac Biotech's earnings are forecast to grow from -$1.06 per share to -- per share next year representing an increase of --.
-
When is Sinovac Biotech's Earnings Date?
Sinovac Biotech's next earnings date is August 15, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
NVIDIA vs Broadcom Stock: Which Is Best?
If you want to invest in an AI-leading tech company,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 117x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Sell
40
MSTR alert for Dec 24
MicroStrategy [MSTR] is up 8.17% over the past day.
Sell
26
NUTX alert for Dec 24
Nutex Health [NUTX] is down 0.76% over the past day.
Sell
48
VRNA alert for Dec 24
Verona Pharma PLC [VRNA] is down 0.55% over the past day.
